Prophylaxis

Il nirsevimab nella prevenzione della bronchiolite da virus respiratorio sinciziale

Consolati A, Farinelli MP, Serravalle P, Rollandin C., Apprato L. , Bongiorno S.

2024/4 — pag. 239-242 — DOI

Background - RSV is the leading cause of hospitalization for respiratory infections in infants, such as bronchiolitis. In the epidemic season 2023-2024, in the Valle D’Aosta Region (VdA) a universal prevention programme against RSV was implemented to...

La profilassi dell’infezione da virus respiratorio sinciziale: dal palivizumab al nirsevimab

Servadio M, Belleudi V, Marchetti F, Addis A.

2022/10 — pag. 632-639 — DOI

The Respiratory Syncytial Virus (RSV) is considered the leading cause of lower respiratory tract infections (LRTI) in children aged < 2 years. In high-risk children, including preterm infants, or in children with bronchopulmonary dysplasia (BPD) and ...

La profilassi della malattia reumatica in Italia

A. Taddio, R. Pillon, S. Pastore, et al.

2020/4 — pag. 249-252

Objective - The aim of the study is to evaluate the compliance rate to secondary prophylaxis and the presence of Rheumatic Heart Disease (RHD) in a cohort of Italian patients with Acute Rheumatic Fever (ARF). Methods - This is a multicentre retrospe...

Osservazione nel neonato a rischio di sepsi precoce

A. Berardi, C. Spada, M. Ciccia, M Capretti, G. Brusa, F. Sandri, E. Balestri, L. Rocca, L. Gambini, M. Azzalli, V. Rizzo, G. Piccinini, E. Vaccina, L. Lucaccioni

2019/6 — pag. 370-376

The approach to the newborn at risk of early-onset sepsis is a challenge. In the past the approach was mainly based on laboratory tests, which were poorly predictive and might cause repeated blood samples and unnecessary antibiotic therapies, with ...

STEWARDSHIP ANTIMICROBICA NEL NEONATO E NEL PICCOLO LATTANTE. Perché e come praticarla

A. Berardi, M. Ficara, E. Pietrella, A. Boncompagni, C. Toffoli, A. Bianchini, E. Della Casa, C. Spada, E. Spaggiari, M. Ciccia, G. Gargano, V. Rizzo, M. Azzalli, G. Biasucci, L. Gambini, S. Bolognesi, G. Piccinini, F. Ferrari a nome del Gruppo per la Prevenzione delle Infezioni da Streptococco B della Regione Emilia-Romagna

2017/8 — pag. 493-501

Antimicrobial resistances are increasing worldwide, due to the misuse of antibiotic therapies in humans as well as in animals. It is expected that within a few decades multi-resistant pathogens will become the leading cause of death worldwide. The ...

Infezione neonatale da Herpes simplex virus

E. Spezia, I. Guidotti, S. Fornaciari, C. Rossi, F. Ferrari, A. Berardi

2014/10 — pag. 630-636

Genital Herpes is one of the most common sexually transmitted genital infection that can be transmitted to the newborn. Neonatal Herpes simplex virus infections can be devastating, so the prevention of mother to newborn transmission is a primary go...

La gestione del nato a rischio di infezione precoce

A. Berardi, I. Guidotti, G. Vellani, C. Rossi, L. Lugli, R. Creti, S. Fornaciari, V. Patianna, F. Ferrari

2013/8 — pag. 507-513

The management of neonates at risk of early-onset sepsis is a challenge. In the last years, the approach has been based on laboratory tests that have been proven to be low predictive. Recent Italian data suggest that a less invasive approach, based...

Neonati e Streptococco di gruppo B: come semplificarsi la vita

S. Demarini

2013/8 — pag. 483-485

L’emofilia nel bambino di oggi

D. Giglia, S. Pasca, G. Barillari

2012/10 — pag. 632-638

Haemophilia A and B are X-linked inherited bleeding disorders, characterized by a posttraumatic or spontaneous high tendency to bleeding and whose severity correlates with plasma levels of a specific coagulative factor. In therapeutic terms remarka...

La profilassi dell’endocardite infettiva: punto e a capo

B. D’Agata, E. Berton, F. Fusco, A. Benettoni, F. Marchetti

2011/7 — pag. 444-447

Guidelines for the prevention of bacterial endocarditis have been recently revised by American Heart Association and European Society of Cardiology. By now, in contrast to previous indications, prophylaxis is recommended only for high risk patients...

Il topiramato nell\'emicrania dell\'adolescente

G. Bartolozzi

2009/4

Il rachitismo in Piemonte: una sorveglianza negli Ospedali

A. Guala, R. Guarino, P. Ghiotti, G. Patrucco, G. Pastore

2006/2 — pag. 119-121

In recent years, the number of children with nutritional rickets has increased in industrialized countries. The vast majority of these cases were born from immigrants and/or non-Caucasians. We conducted a retrospective study on all children discharge...

Il Pneumocisti Carinii

M. Lazzerini

2004/11

Profilassi del rachitismo e prospettive di ulteriore impiego

C. Locatelli

2004/8

Lo zanamivir: un aggiornamento del suo uso nell'influenza

G. Bartolozzi

2003/10

Profilassi dell’endocardite batterica

F. Marchetti

1998/3 — pag. 185-187

Guidelines for prevention of bacterial endocarditis have been recently revised by the American Heart Association and approved by the American Academy of Pediatrics. The revised guidelines aim at simplifying both eligibility criteria and antibiot...